Home +8801575308158
LuciErda 3 Mg (Erdafitinib)

LuciErda 3 Mg (Erdafitinib)

LuciErda (Erdafitinib) 3 mg is a targeted kinase inhibitor indicated to treat adults with locally advanced or metastatic urothelial carcinoma (a form of bladder cancer). It is used specifically for tumors with susceptible FGFR3 or FGFR2 genetic alterations that have progressed despite prior platinum-based chemotherapy.

Category: Brand:
WhatsApp QR

Scan to Order

Order Now +8801575308158
Details:
  • Condition: Advanced or metastatic urothelial carcinoma (mUC).
  • Requirement: The presence of FGFR3 or FGFR2 genetic alterations must be confirmed in tumor specimens before starting treatment.
  • Administration: Tablets are swallowed whole and can be taken with or without food.
  • Dosage: The appropriate dose is determined by an oncologist based on specific criteria and patient response.

Reviews

There are no reviews yet.

Be the first to review “LuciErda 3 Mg (Erdafitinib)”

Your email address will not be published. Required fields are marked *

Related products

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are Trusted Cancer Medicine seller.

Quick Links

Categories

Brands

Copyright © 2026 dcenbd.com. All right Reserved.
Scroll to Top